BJCM
BSX icon

Blue Jay Capital Management’s Boston Scientific BSX Stock Holding History

Blue Jay Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-498,303
Closed -$10.8M – 22
2016
Q4 		$10.8M Buy
+498,303
New +$10.9M 6.5% 10
2016
Q3 		– Sell
-469,900
Closed -$11M – 18
2016
Q2 		$11M Buy
+469,900
New +$10.2M 7.21% 7

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Blue Jay Capital Management's BSX Position: Q1 2017 in Review

Blue Jay Capital Management sold out of Boston Scientific (BSX) in Q1 2017, closing a stake of 498,303 shares — an estimated $10.8M sold.

Blue Jay Capital Management first reported a position in BSX in Q2 2016 and held it in 2 quarters. The position peaked at $11M in Q2 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • Blue Jay Capital Management reported no remaining Boston Scientific position as of Q1 2017 after selling out during the quarter.
  • Blue Jay Capital Management sold 498,303 Boston Scientific shares in Q1 2017, an estimated $10.8M.
  • Blue Jay Capital Management first reported a position in Boston Scientific in Q2 2016 and held it in 2 quarters.
  • Blue Jay Capital Management's Boston Scientific position peaked at $11M in Q2 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on Blue Jay Capital Management's 13F filing for Q1 2017, filed 12 May 2017.